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Abstract
Background: Group A Streptococcus strains causing wide variety of diseases, recently became noticeable in
eastern India, are not amenable to standard treatment protocol thus enhancing the possibility of disease morbidity
by becoming antibiotic resistance.
Methods: The association of Lancefield group A Streptococcal variation with degree of vir architectural diversity
was evaluated using emm typing and restriction fragment length polymorphism analyses. The antibiotic sensitivity
patterns were examined by modified Kirby-Bauer method of disk diffusion. Percentage calculations, 95% confidence
interval and one-way ANOVA were used to assess differences in proportions.
Results: Our observations revealed 20 different emm types and 13 different HaeIII vir typing patterns. A 1.2 kb
fragment was found in all HaeIII typing pattern. Fragments of 1.2 kb and 550 bp were conserved in majority of the
isolates. HinfI digestion was found proficient in differentiating the strains of same vir typing patterns. Strong
predominance of speC (85%) and speF (80%) genes have been observed encoding exotoxins production. 4 isolates
were found to be erythromycin resistant and were of genotype emm49. High degree of tetracycline resistance was
shown by 53.57% isolates which belonged to 12 different emm genotypes.
Conclusions: These findings suggested that in addition to emm typing, sequential application of HaeIII and HinfI
restriction enzymes in vir typing analysis is an effective tool for group A streptococcal molecular characterization
associated with antibiotic resistance.
Keywords: Streptococcus pyogenes (GAS), emm typing, vir typing, Virulence regulon, Restriction enzyme digestion,
Antibiotic sensitivity patterns, Exotoxin gene
Background
Streptococcus pyogenes or Lancefield group A Streptococ-
cus (GAS) is responsible for a diverse range of clinical
manifestations. Acute infection causes pharyngitis,
impetigo, scarlet fever, cellulitis, acute bacterial endocar-
ditis and necrotizing fasciitis. Ineffective or delayed
treatment, and infection with drug-resistant bacteria
eventuates in chronic immune-mediated disorders such
as acute rheumatic fever (ARF) and acute glomerulo-
nephritis (AGN) with attended morbidity and mortality
worldwide [1–6].
The fast emergence of antimicrobial resistance amongst
S. pyogenes therefore needs molecular characterization of
the newly variant strains. The conventional M serotyping
is cumbersome, less effective and demand preparatory
requirements [7, 8]. A large number of S. pyogenes isolates
remains M untypable by the available present range of
high titre antisera [9–11]. Alternative techniques used for
emm and vir typing are favored. emm typing is based on
sequence analysis of emm gene [8], that encodes for the
major virulence factor M and M-like proteins while vir
typing is based on amplification of virulence regulon-
specific polymerase chain reaction (PCR) amplicon
followed by restriction fragment length polymorphism
(RFLP) [12].
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Different reports have shown a fair prevalence of GAS
infections among children [6, 13, 14] and strain varia-
tions among the GAS isolates [15, 16]. A sudden world-
wide increase in antimicrobial resistance in S. pyogenes
has been observed during the last few years [17, 18].
Macrolide resistance among GAS has been widespread
[19, 20] possibly linking to the spread of a particular
clone by selection pressure due to random usage of
macrolides [21]. Recent reports on tetracycline resist-
ance identify the ineffectiveness of this drug against
infections with GAS [22–26]. Streptococcal pyrogenic
exotoxins act as super antigens and stimulate lympho-
cyte activation to induce fever and extensive prolifera-
tion with the consequent massive release of cytokines
[27]. Fibronectin binding proteins are considered as
major Streptococcal adhesins and amongst them fbp54
is expressed in human host environment [28].
Reports on Streptococcal pyrogenic exotoxin genes
and fibronectin binding protein gene expression in non-
invasive infections are relatively few from India. The
present study tries to establish the correlation of the
GAS genotypic variation with the changes in molecular
patterns of virulence regulon, antibiotic resistance and
expression of pyrogenic exotoxins and fibronectin bind-
ing protein genes.
The isolates have been characterized with HaeIII, HinfI
and XhoI restriction fragment length polymorphism to
evaluate their applicability in vir typing analysis follow-
ing methodology by Gardiner et al. [9, 12].
Methods
Isolate selection
The patients presenting with sore throat, different skin
lesions and on clinical examination found to be suffering
from pharyngitis and/or tonsillitis and pyoderma were
selected for study. Samples were collected before admin-
istering any antibiotic therapy.
Patient recruitment
Study patient samples belonged to four age-groups:
Group I 1 month to 3 years [infants]
Group II 4 years to 15 years [school-aged children]
Group III 16 years to 45 years [adults]
Group IV >45 years [middle as well as old age groups]
Detailed clinical history, which includes types of
throat infections and skin infections, the period of
suffering, was recorded. Age, sex, home address and
other information of the patients were recorded. S.
pyogenes was isolated from the samples at the Depart-
ment of Biochemistry of Dr. B C Roy Post Graduate
Institute of Basic Medical Education and Research
(IPGME&R), Kolkata.
Collection of samples from sore throat patients
Samples for throat culture were obtained by swabbing
the patient’s posterior part of upper respiratory tract
with a sterile cotton swab.
Collection of samples from patients with skin infections
Pus samples were collected using a sterile swab stick
from ulcerative lesion of pyoderma infections. In case of
unopened abscess pus was collected by aspiration.
We got very insignificant number of S. pyogenes
isolates (two isolates) from throat samples. Therefore we
have summarized and interpreted our observations in re-
spect to non-sever infections which include sore throats
and pyoderma/ impetigo. It has been done to avoid any
bias that might occur during interpretation of the
results.
Sample isolation and storage
Samples were inoculated in 5% sheep blood agar and in-
cubated at 37 °C for 24–48 h. β- hemolytic colonies were
selected and screened by Gram staining, bacitracin sus-
ceptibility test, catalase test, and finally confirmed as
Group A Streptococcus by Latex agglutination test using a
Streptex kit (Remel, UK). Isolates were stored at −80 °C in
Brain Heart Infusion Broth containing 30% glycerol.
emm typing analysis
emm typing is based on sequence analysis of emm gene
encoding for serotype specific M-protein. Genomic
DNA was prepared by phenol-chloroform method [29]
from bacteria obtained by touching the tips of β-
hemolytic single colonies, obtained by subculture from
overnight broth culture (BHI broth, Hi-media, Mumbai,
India), to avoid contamination in growth in liquid
medium. Bacterial cells were treated with mutanolysin
and lysozyme solution for 1 h at 37 °C. For emm typing
analysis, gene was amplified by “all M” primers [15, 30],
using PTC150 (MiniCyclerTM, MJ Research) thermal cy-
cler. PCR amplicon of about 1.4 kb was then sequenced
with the forward primer (5′ ATAAGGAGCATAAA
AATGGCT 3′). Sequencing was done commercially
(Chromous Biotech Pvt. Ltd., India). The sequence
was subjected to homology search by Blast search
analysis (http://www.cdc.gov/ncidod/biotech/strep/ strep-
blast.htm). Pair-wise comparison of the nucleotide iden-
tities of the first 180 to 200 bases of the N-terminal
hypervariable region was conducted and strains which
showed ≥ 95% homology with the reference strains were
assigned the particular parental emm type [15].
vir typing analysis
vir typing is based on amplification of virulence regulon
that encode for different GroupA Streptococcal virulent
proteins. Amplification of vir regulon specific PCR
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amplicon was performed by VUF and SBR primers, as
described by Gardiner et al. [12], with few modifications.
PCR amplification was carried out in a 50 μl reaction
mixture containing 5 μl of template DNA, 1U of TaKaRa
LA Taq polymerase, LA PCR Buffer II, 2 mM MgCl2,
200 μM of each of dATP, dGTP, dCTP and dTTP, 1 μl of
each 20 μM primers. Cycling conditions were modified
to include a final extension at 72 °C for 7 min. Then 5 μl
of PCR product was electrophoresed on 0.8% agarose gel
to check the quality as well as the quantity of the ampli-
con. RFLP was carried out in 30 μl reaction containing
0.5 μg (10-15 μl) PCR product, RE buffer, 2U of HaeIII /
HinfI / XhoI restriction enzyme from NEB [9, 12]. Diges-
tion was carried out for 1 h 30 min. Digests were elec-
trophoresed on 1% agarose gel and band patterns were
analyzed by visual comparison.
Identification of toxin and fibronectin-binding protein
genes
Sequences specific for speA, speB, speC, speF and fbp-54
were detected with the primers documented by earlier
workers [31]. The primer sequences, annealing
temperature and amplicon sizes are given in Table 1.
Amplification of all genes was carried out under the fol-
lowing conditions: an initial 5 min denaturation step at
96 °C, followed by 30 cycles of denaturation at 96 °C for
55 s, 65 s of annealing at the appropriate temperature
for each gene (Table 1), and 70 s of extension at 72 °C,
with a final extension step at 72 °C for 5 min. All PCR
products were electrophoresed on 1.5% agarose gels.
φX174 DNA ladder (GeNeiTM) and 100 bp Gene ruler
(Fermentus) were used as molecular marker.
Determination of antibiotic susceptibility
The antibiotic sensitivity of all GAS isolates were tested
by the modified Kirby-Bauer method, matching inocu-
lum turbidity to McFarland 0.5 [32], on Mueller-Hinton
agar with 5% sheep blood using penicillinG (10unit),
cefotaxime (30 μg), erythromycin (15 μg), vancomycin
(30 μg), tetracycline (30 μg) and clindamycin (2 μg)
[HiMedia, India] disks. Results were interpreted
according to Clinical and Laboratory Standards Institute
(CLSI) guidelines provided by the CLSI, 2012, as per
manufacturer’s instructions [33]. Streptococcus pyogenes
ATCC19615 strain was used as control.
Statistical analysis
Majority of counts have been summarized by percent-
ages, key proportion has been expressed within 95%
confidence interval. Statistical analysis was done using
one-way ANOVA. P value with P < 0.05 was considered
significant, a difference with P < 0.0001 was considered
highly significant.
Results
Isolation of Streptococcus pyogenes and emm genotype
diversity
Samples were collected from tertiary referral health care
hospitals in Kolkata. As these are the most important re-
ferral Government hospitals, a large number of patients
from different community attend these hospitals. Prior
informed consent and clearance from institutional eth-
ical committee were obtained. Samples were collected
from patients attending skin and E.N.T OPD of Seth
Sukhlal Karnani Memorial Hospital (SSKM) hospital and
Calcutta National Medical College & Hospital, from
2009 to December, 2011.
Detailed analysis of isolates from 270 cases identified
140 (51.8%) as GAS expressing interpretable emm types.
These isolates represented 20 different emm types, indi-
cating 14.28% heterogeneity. The sizes of the amplicon
were around 1.4 kb. The most common emm types
among the obtained emm types was emm49 (Additional
file 1) (17.85%), followed by emm25 (Additional file 2)
(12.14%), emm77 (10.71%). The observed frequency for
each of emm9, emm80, emm92 and emm81 was 6.42%.
Others were found in very low percentages (Fig. 1a).
Regarding correlations of emm typing with age groups,
our observations revealed that infants (1 month–3 years)
were frequently infected by emm49 (75%; P value
<0.0001), whereas 18.7% school aged children (group II)
were affected by emm25 (P value =0.0004), followed by
Table 1 Sequences of the PCR primers
Target gene Primer sequence (5′-3′) Annealing temp (°C) Amplicon size (bp) Reference
speA FW-5΄-TAA GAA CCA AGA GAT GG-3΄
RV-5΄-ATT CTT GAG CAG TTA CC-3΄
44 248 Vlaminckx et al., [31]
speB FW-5΄-AAG AAG CAA AAG ATA GC-3΄
RV-5΄-TGG TAG AAG TTA CGT CC-3΄
42 955
spec FW-5΄- GAT TTC TAC TTA TTT CAC C-3΄
RV-5΄-AAA TAT CTG ATC TAG TCC C-3΄
42 584
speF FW-5΄- TAC TTG GAT CAA GAC G-3΄
RV-5΄-GTA ATT AAT GGT GTA GCC-3΄
42 782
fbp-54 FW-5΄-CTT CAG AAT CTG TTT CTT TG-3΄
RV-5΄-AGT TCA CAG GTT GTC TAT TG-3΄
48 595
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emm92 genotype (14.5%; P value =0.001). A few emm
strains were found in adults belonging to group III
(15.6% of emm77; P value =0.008), and middle or old
aged patients in group IV (16.6% of emm9, emm25 and
emm11 each; P value =0.0004) (Fig. 2).
vir typing patterns diversity
In the present study, 13 different vir types among 140
isolates (9.2%) were observed. vir types had been identi-
fied by RFLP with HaeIII restriction enzyme. All isolates
were typeable with HaeIII enzyme, showing 3–7 bands
ranging from 200 bp to 4 kb. The isolates showed a
common band at 1.2 kb, and majority of isolates shared
fragments at around 200 bp and 550 bp (Fig. 3). Out of
13 different vir types, the most commonly found vir type
was VT8 (27.14%), followed by VT4 (17.14%), VT3 (11.4%),
VT12 (10%) and VT7 (8.57%). In our study VT1 repre-
sented the reference strain type of ATCC 19615 (Fig. 1b).
On comparing emm genotype with HaeIII vir typing
patterns, it was found that emm49, emm25, emm80,
emm12 matched with co-existence of VT8, VT3, VT1
and VT4 respectively. In contrast, VT8 was also associ-
ated with emm65, emm11, emm77, and VT12 with
emm92 and emm9. VT3 pattern was observed both in
emm25 type and emm25.1 subtype. On the other hand,
emm81/ emm81.1 were noted with VT11 and VT9 re-
spectively, and emm1/ emm1.1 with VT6, VT10 respect-
ively (Table 2).
The second restriction enzyme HinfI, documented 21
different vir typing patterns (VT1-VT21). HinfI digestion
was found to generate 6–10 bands, which were around
250 bp to 2 kb (Fig. 4a & b). HinfI was found to generate
same or different typing patterns for the isolates those
producing identical HaeIII typing patterns. In comparing
the typing patterns of HaeIII and HinfI digestions, HinfI
enzyme was found to discriminate VT8 HaeIII digestion
type into five more subtypes (VT3, VT4, VT8, VT12, and
VT16), VT4 HaeIII type into another four more subtypes
(VT2, VT6, VT7, VT18) and each of VT1, VT2, VT3 into
two more subtypes (Table 2).
In our study, the third restriction analysis by diges-
tion with XhoI recognized 6 different typing patterns
(VTi-VTvi), with fragments around 1 to 6 kb among
140 isolates (Fig. 5). Study showed the most frequent
VT patterns by XhoI digestion were 34.28, 14.99, and
12.85% for VTv, VTiii and VTiv respectively. VTvi,
showing only a minor band, was found in 24.99%
isolates.
Identification of exotoxin and fibronectin-binding protein
genes
Study highlighted that only 6 (4.2%) isolates was
found to contain speA gene, whereas majority of iso-
lates contained speC (85%) and speF (80%) genes. The
rate of occurrence of speB and fbp-54 genes was 58
and 30%, respectively.
Fig. 1 Distribution of different emm types (a) and HaeIII vir types (b) among isolates. 140 isolates yielded interpretable emm types and HaeIII vir
types. Genomic DNA was prepared using the phenol-chloroform method. emm gene was amplified by “all M” primers and further sequenced with
“all M” forward primer. The sequences were subjected to homology search by Blast search analysis (http://www.cdc.gov/ncidod/biotech/strep/
strepblast.htm) as described in Methods. GAS isolates represented 20 different emm types. The most predominant emm types found were emm49
(17.85%), followed by emm25 (12.14%), emm77 (10.71%). emm9, emm80, emm92 and emm81 was observed in 6.42%. Rests were found in very
low percentage (a). vir regulon specific amplicon was amplified by VUF and SBR primers and resolved on 0.8% agarose gel. RFLP was further
carried out using HaeIII restriction enzyme and products were resolved on 1% agarose gel. Out of 13 HaeIII vir types, the most commonly found
vir type was VT8 (27.14%), followed by VT4 (17.14%), VT3 (11.4%), VT12 (10%) and VT7 (8.57%) (b)
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Fig. 3 1% Agarose gel containing RFLP profile (vir type) of HaeIII digested PCR products. Genomic DNA was prepared using the phenol-chloroform
method. vir regulon specific amplicon was amplified by VUF and SBR primers and resolved on 0.8% agarose gel. RFLP was further carried
out as described in Methods using HaeIII restriction enzyme and products were resolved on 1% agarose gel. Lane 1 = 10 kb Super mix
marker; Lanes 2-14 = VT1- VT13
Fig. 2 Distribution of different emm types among age groups. Patient samples were categorized in four age-groups as mentioned in
Methods. Genomic DNA was prepared using the phenol-chloroform method. emm gene was then amplified by “all M” primers and further
sequenced with “all M” forward primer. The sequence obtained was then subjected to homology search by Blast search analysis (http://
www.cdc.gov/ncidod/biotech/strep/ strepblast.htm). Distribution of different emm types among age groups was expressed in percentages
as described in Methods. emm types of group A streptococci isolated from different age groups revealed that infants (1 month–3 years)
are frequently infected by emm49 (75%), school-going children (group II) are primarily affected by emm25 (18.7%) and emm92 (14.5%). A
few emm strains were detected in adults (group III, 15.6% of emm77) and middle or old aged patients (group IV 16.6% of emm9, emm25
and emm11 each). Asterisks indicate a statistically significant correlations (****P < 0.0001, ***P = 0.0004 and **P = 0.001, 0.008)
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Evaluation of antibiotic susceptibility patterns of
S. pyogenes
In the present study, isolates were found highly sensitive
(76.42%) to penicillin with 23.57% of intermediate sus-
ceptibility. Erythromycin sensitivity was very high
(88.57%), and only 4 (2.85%) found resistant (95% CI-
0.09%–05.61). All isolates were susceptible to vanco-
mycin and clindamycin. Cefotaxime sensitivity was very
high (91.42%) with only 8.57% of isolates showing inter-
mediate sensitivity. By contrast, resistance (53.57%) and
intermediate resistance (21.42%) to tetracycline were
high (Table 3).
Correlation of antibiotic susceptibility patterns with emm
typing
Relation between emm types and antibiotic sensitivity
patterns was evaluated for studying their correlations.
Strain emm43.3 and emm9 were found to be sensitive to
all six antibiotics. Three children and one adult showing
erythromycin resistance cases were of genotype emm49.
Out of 20 emm types documented, 12 emm types were
found responsible for tetracycline-resistance (Table 4).
Discussion
In the present study, the emm and vir type diversity
among GAS isolates obtained from different patients
was analyzed. Reports by earlier workers documented
57.5, 19.71 and 40% heterogeneity with emm49, emm77
and emm74 genotypes to be the most prevalent types re-
spectively [15, 34, 35]. In another study, 32.35% hetero-
geneity was reported [16]. A Norweigian study revealed
44% variation with emm1 to be the most prevalent geno-
type [36]. In a recent outbreak of GAS infections, the
most uncommonly reported emm type 58 was shown to
be most frequent isolate [37].
In present study, emm typing resulted in 14.28% het-
erogeneity in the isolated GAS strains which is indicative
of lower strain variation in this context. The most de-
tectable type found was emm49 (17.85%). Thus different
values of heterogeneity in the isolates were observed by
the present and earlier investigators, might be due to
variation of prevalent strains in different geographical
regions having different climatic conditions. It could
possibly be predicted that the genetic heterogeneity
Fig. 4 1% Agarose gel containing RFLP profile (vir type) of HinfI digested PCR products. Genomic DNA was prepared using the phenol-chloroform
method. vir regulon specific amplicon was amplified by VUF and SBR primers and resolved on 0.8% agarose gel. RFLP was performed
using HinfI restriction enzyme and the products were resolved on 1% agarose gel. Lane 1 = 10 kb Super mix marker; Lanes 2-10 = VT1 - VT9 ;
Lane11 = 100 bp marker (a). Lane 1 = 10 kb Super mix marker; Lanes 2-13 = VT10 -VT21; Lane 14 = 100 bp marker (b)
Table 2 Comparison of emm typing/HaeIII vir typing/ HinfI vir
typing of GAS isolates
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could be temperature and humidity dependent, however
this fact requires a complete different investigation. The
results of this study demonstrated some emm types and
their subtypes, like emm81/emm81.1, emm25/emm25.1
and emm1/emm1.1, emerged due to point mutation,
reflecting in the origin of N-terminal emm sequence
variability and implying the importance of emm strain
typing (sequencing data not shown).
As children are more susceptible to GAS infections
[38–40], and as associated emm-types and clinical pre-
sentations are influenced by population immunity and
strain tropism [41], the emm distribution patterns in re-
lation to patient’s age, the children in particular, are
significant. In this study occurrence of S. pyogenes infec-
tion was found average. As children are more susceptible
to GAS infections with attendant life-threatening remote
sequelas (RHD and AGN) as well, it is believed that the
dominance of emm49 as well as other frequently occur-
ring emm types in infant and children needs an inde-
pendent and systematic study on association of
immunological parameters with emm types.
Vir typing measures the changes in the region of the
genome that determines major virulence factors that are
involved in anti-phagocytic activity, attachment,
colonization and in avoiding recognition by the immune
systems [12]. The HaeIII vir typing patterns in the
present study were found dissimilar to other reported
typing patterns. So we assigned our own VTs to analyze
the typing patterns of the isolates from eastern region of
India. We screened 13 vir types from 140 isolates by
HaeIII digestion, which accounted 9.28% diversity in
GAS isolates. Here we observed that vir types were en-
tirely different from the reported typing patterns of
Australia, Romania and northern India. HaeIII vir typing
patterns of Australian GAS isolates produced 4 to 8
fragments ranging from 200 bp to 4 kb, where 1.4 kb,
500 bp, and 275 bp were found common in the isolates
tested [9]. vir typing patterns of Romania yielded 2 to 8
fragments ranging from 100 bp to 4.2 kb with a com-
mon fragment at 1.2 kb [42]. Reports from north India
showed 4 to 6 fragments varying from 300 bp to 5 kb
where 300 bp, 550 bp and 1.2 kb were common for the
majority of isolates [15]. We found 3 to 7 fragments of
200 bp to 4 kb and a 1.2 kb fragment was found com-
mon to all isolates. The majority of isolates shared the
fragments of around 200 bp (81.42%) and 550 bp
(87.85%). On comparing our present findings with those
previous observations, a 1.2 kb fragment was found
common in most of the study regions (except Australian
typing patterns). In India, in addition to 1.2 kb, a 550 bp
was also found common to the majority of isolates.
Thus, these two segments of the virulence regulon of
S. pyogenes remain conserved in Indian strain types.
The overlaps between emm and vir typing showed that
one specific emm type was always represented by one





Patterns of susceptibility (in percentage) with respect to diameter of zone of inhibition in mm
Resistant Intermediate Sensitive
1. PenicillinG (10unit) - 33 (23.57%) 107 (76.42%)
2. Erythromycin (15mcg) 4 (2.85%) 12 (8.57%) 124 (88.57%)
3. Cefotaxime (30mcg) - 12 (8.57%) 128 (91.42%)
4. Vancomycin (30mcg) - - 140 (100%)
5. Tetracycline (30mcg) 75 (53.57%) 30 (21.42%) 35 (24.99%)
6. Clindamycin (2mcg) - - 140 (100%)
Fig. 5 1% Agarose gel containing RFLP profile (vir type) of XhoI
digested PCR products. Genomic DNA was prepared using the
phenol-chloroform method. vir regulon specific amplicon was
amplified by VUF and SBR primers and resolved on 0.8% agarose
gel. RFLP was performed using XhoI restriction enzyme and the
products were resolved on 1% agarose gel. Lane 1 = 10 kb Super
mix marker; Lanes 2-7 = VTi- VTvi
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particular vir type whereas one vir type was shared by
more than one emm types. However, in two cases, differ-
ent VTs were obtained for isolates of one emm type and
its subtype. This finding supports the concept that the
heterogeneity demonstrated by vir typing is primarily
due to variations among emm genes rather than diversity
in the architecture of the vir regulon [9] and thus, an in-
sertion or deletion of one or more nucleotide not only
categorizes a specific emm type into its subtypes but also
changes the expression of its virulence regulon. Thus vir
typing analysis is found more informative than emm typ-
ing, regarding architectural variation of virulence regu-
lon conferring the virulence on S. pyogenes.
Furthermore the use of the second restriction enzyme
HinfI appeared to be very useful in discriminating HaeIII
typed isolates, which supports the concept of Gardiner
et al. [9]. In the present study, though HinfI was found
proficient in distinguishing the isolates of the same
HaeIII vir types and also generate more fragments com-
paring HaeIII but it did not generate any conserved frag-
ments, unlike HaeIII digestion. Therefore, successive use
of these two enzymes can be a tool for vir typing ana-
lysis. XhoI digestion produced fewer fragments and was
less informative.
In order to study the strain characteristics contributing
to virulence patterns, the isolates were evaluated for the
presence of different toxin and fibronectin binding pro-
tein genes. Extracellular proteins that reportedly play a
role in the pathogenesis of GAS are represented by
streptococcal exotoxins, a few of which have superanti-
genic properties that allow them to activate large subsets
of T cells, with massive cytokine release as a conse-
quence [31]. Previous report from India showed lower
incidence of speA gene (5.8%) and higher incidence of
speB and speF gene (92.3, 86.5%) in noninvasive infec-
tion [43]. In contrast, the current study showed speA
gene less contributing for GAS infections, whereas the
observed predominant occurrence of speC and speF
genes strongly suggest their association with incidence
of infections. Association of SpeB and fbp-54 genes was
noticed in less number of cases and probably partly con-
tributes towards virulence. It is of considerable interest
to study the correlation of these exotoxin gene expres-
sions with cytokines activation in this region by further
study.
Another important aspect of this study is GAS anti-
biotic sensitivity patterns and their correlation with emm
genotyping. Penicillin has been used routinely for treat-
ing GAS infections for over 50 years, and yet GAS has
remained penicillin susceptible [44, 45]. Since penicillin
may be given at higher doses without ill effects, the ob-
served intermediate sensitivity in our study may have
less impact. A study from north India [7] showed dimin-
ished susceptibility in 20.6% of strains which is in sup-
port of our observation but contrast to previous reports
of 100% susceptibility [46, 47]. Erythromycin resistance
and therapeutic failure have been observed to be on the
rise worldwide due to their increased medicament
[48–50]. In this study, sensitivity to erythromycin was
found very high. The observed erythromycin resistant
cases were though small in number, but alarming in this
region as these were obtained mostly from children, and
erythromycin is the 1st alternative drug of choice for peni-
cillin hypersensitive patients as well. Interestingly, all four
erythromycin resistant strains were of genotype emm49,
suggesting that the genotype’s association with the emer-
ging erythromycin-resistance in this region. Association
of erythromycin resistance and emm typing has been
documented earlier. emm12 from Korea and Japan [51],
emm12 and emm75 from Pittsburgh [52], emm90 from
Hawaii [53], emm 4, emm 28, and emm 77 from Western
Greece [54] showed strong association with erythromycin
resistance. In present study, association is different from
earlier workers as emm49 was constantly associated with
the erythromycin resistance. In spite of clindamycin resist-
ance report [55] earlier, all isolates of present study were





Susceptibility of emm types
Sensitive Intermediate Resistant
1. PenicillinG emm-25, 25.1, 49, 80, 9, 11, 81, 81.1, 43.3, 106, 41, 92, 77, 55,
1
emm-112.2, 25, 49, 81, 1.1,
65, 80.1, 12
-
2. Cefotaxime emm-25, 25.1, 49, 80, 80.1, 9, 11, 81, 81.1, 106, 41, 43.3, 92,
77, 55, 1, 1.1
emm-25, 49, 81, 12, 112.2,
65
-
3. Erythromycin emm-43.3, 25, 25.1, 49, 80, 80.1, 9, 11, 12, 81, 81.1, 106, 41,
92, 77, 55, 1, 1.1
emm-49, 112.2, 65, 1 emm-49
4. Clindamycin emm-25, 25.1, 49, 43.3, 80, 80.1, 1, 1.1, 9, 11, 12, 81, 81.1, 106,
41, 92, 77, 55, 112.2, 65
- -
5. Tetracycline emm-25, 43.3,49, 9, 77, 80.1, 81, 65 emm-25.1, 80, 49, 81, 81.1,
12
emm-1, 1.1, 41, 55, 81, 81.1, 77, 49,
11, 106, 112.2, 92
6. Vancomycin emm-25, 25.1, 49, 43.3, 80, 80.1, 1, 1.1, 9, 11, 12, 81, 81.1, 106,
41, 92, 77, 55, 112.2, 65
- -
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found sensitive to clindamycin and vancomycin. High
tetracycline resistance among S. pyogenes isolates have
been reported from different parts of the World [22, 44,
56, 57]. In the present study, high percentage of resistance
was shown by tetracycline, which is in corroboration with
the previous findings. 14 and 28 different tetracycline-
resistant emm types were identified in studies from Spain
and Tunisia, respectively [58, 59]. Present study identified
75 tetracycline-resistant isolates, belonging to 12 different
emm genotypes. These findings indicated that for study of
different regions, S. pyogenes strains are approaching
tetracycline-resistance, attributable to modifications in tet
(M) gene commonly associated with the conjugative
transposon Tn916 [59].
Conclusion
The findings in this study highlight a novel vir-emm cor-
relative dual genotyping analysis with implications in the
development of a universally effective vaccine and a new
diagnostic tool. speC and speB exotoxins may have im-
portant contribution to noninvasive Streptococcal infec-
tions. Observations on antibiotic sensitivity patterns
emphasized the need for continued monitoring of anti-
biotic sensitivity and genotyping of S pyogenes for redu-
cing the burden of antibiotic resistance.
Additional files
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